#VisualAbstract: Psilocybin can reduce depressive symptoms in patients with treatment-resistant depression
Click here to read this study in NEJM.
Read MoreNov 19, 2022
Click here to read this study in NEJM.
Read MoreNov 17, 2022
1. Patients assigned to renal artery denervation had significantly lower office and ambulatory...
Read MoreNov 17, 2022
1. Median overall survival was longer in patients receiving steroid-only treatment for adverse...
Read MoreNov 12, 2022
Click here to read this study in NEJM
Read MoreNov 11, 2022
Click here to read this study in JAMA.
Read MoreNov 11, 2022
Click here to read this study in NEJM
Read MoreNov 11, 2022
Click here to read this study in NEJM.
Read MoreNov 11, 2022
1. The primary composite cardiovascular endpoint was similar among patients in the evening and...
Read MoreNov 11, 2022
Click here to read this paper in NEJM.
Read MoreNov 11, 2022
1. In a systematic review with meta-analysis, COVID-19 vaccination during pregnancy was associated...
Read MoreOct 31, 2022
1. In patients with type 1 diabetes, using intermittently scanned continuous glucose monitoring...
Read MoreOct 27, 2022
1. The median progression-free survival was higher in the enzalutamide vs the placebo group (9.5...
Read MoreOct 27, 2022
Click here to read this study in JAMA.
Read MoreOct 27, 2022
1. In comparison to the best available medical care, a greater proportion of patients with...
Read MoreOct 27, 2022
Click here to read this study in NEJM.
Read MoreOct 25, 2022
Click to read this study in JAMA.
Read MoreOct 23, 2022
Click here to read this study in NEJM.
Read MoreOct 23, 2022
Click here to read this study in JAMA Psychiatry.
Read MoreOct 21, 2022
Click to read this study in JAMA Otolaryngology – Head & Neck Surgery.
Read MoreOct 21, 2022
1. Pembrolizumab-alone or pembrolizumab-chemotherapy prolonged overall survival vs...
Read More